CHARACTERIZATION OF GENOMIC LANDSCAPES OF BRCA1 AND BRCA2 IMPLICATED OVARIAN CANCER SPECIMENS FROM A FOUNDER FRENCH CANADIAN POPULATION

被引：0
|
作者：
AlShehri, E. [1 ]
Arcand, S. [1 ]
Oros, K. [2 ]
Greenwood, C. [2 ]
Tonin, P. [1 ]
机构：
[1] McGill Univ, Ctr Hlth, Res Inst, Human Genet, Montreal, PQ, Canada
[2] Jewish Gen Hosp, Lady Davis Inst Med Res, Bioinformat, Montreal, PQ, Canada
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2016年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCS-1164
引用
收藏
页码：175 / 175
页数：1
相关论文
共 50 条
  • [1] Characterization of genomic landscapes of BRCA1 and BRCA2 implicated ovarian cancer specimens from a founder french canadian population
    AlShehri, Eman
    Belanger, Moria
    Arcand, Suzanna
    Oros, Kathleen Klein
    Greenwood, Celia
    Tonin, Patricia N.
    [J]. CLINICAL CANCER RESEARCH, 2015, 21
  • [2] Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families
    Tonin, PN
    Mes-Masson, AM
    Futreal, PA
    Morgan, K
    Mahon, M
    Foulkes, WD
    Cole, DEC
    Provencher, D
    Ghadirian, P
    Narod, SA
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (05) : 1341 - 1351
  • [3] Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history
    Tonin, PN
    Mes-Masson, AM
    Narod, SA
    Ghadirian, P
    Provencher, D
    [J]. CLINICAL GENETICS, 1999, 55 (05) : 318 - 324
  • [4] Prevalence of BRCA1 and BRCA2 mutations in ovarian cancer patients from the French-Canadian population.
    Guenard, F
    Klappenberger, S
    Labrie, Y
    Plante, M
    Tetu, B
    Durocher, F
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 233 - 233
  • [5] Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer
    Chappuis, PO
    Hamel, N
    Paradis, AJ
    Deschênes, J
    Robidoux, A
    Potvin, C
    Cantin, J
    Tonin, P
    Ghadirian, P
    Foulkes, WD
    [J]. CLINICAL GENETICS, 2001, 59 (06) : 418 - 423
  • [6] Identification and Characterization of BRCA1 and BRCA2 Founder Mutations
    Sidoni, T.
    Cocciolone, V
    Giannini, G.
    Russo, A.
    Baudi, F.
    Cannita, K.
    Ficorella, C.
    Iacobelli, S.
    Ricevuto, E.
    [J]. CURRENT WOMENS HEALTH REVIEWS, 2012, 8 (01) : 17 - 22
  • [7] The Contribution of BRCA1 and BRCA2 to Ovarian Cancer
    Ramus, Susan J.
    Gayther, Simon A.
    [J]. MOLECULAR ONCOLOGY, 2009, 3 (02) : 138 - 150
  • [8] Inactivation of BRCA1 and BRCA2 in ovarian cancer
    Hilton, JL
    Geisler, JP
    Rathe, JA
    Hattermann-Zogg, MA
    DeYoung, B
    Buller, RE
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (18) : 1396 - 1406
  • [9] BRCA1 and BRCA2 Mutations in Ovarian Cancer
    Buerkle, Bernd
    Tempfer, Clemens
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04): : 359 - 359
  • [10] The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada
    Tonin, Patricia N.
    [J]. BULLETIN DU CANCER, 2006, 93 (09) : 841 - 846
12345